CORISMA
Spun out of the Bonde Artificial Heart Lab at Yale University, Bonde Innovations is developing an innovative, catheter implanted circulatory assist device, CoRISMA, to treat Class 3 and Class 4 heart failure patients. With $2M+ grant funding, CoRISMA has been designed to improve patients' quality of life and reduce cost and invasiveness associated with the current therapies. All the components of the devices have been prototyped and tested at Yale.
CORISMA
Social Links:
Industry:
Health Care Life Science Therapeutics
Founded:
2018-08-09
Address:
Bethany, Connecticut, United States
Country:
United States
Website Url:
http://www.corismacv.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
27 M USD
Technology used in webpage:
Microsoft Exchange Online
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Current Employees Featured
Founder
Investors List
China Grand Pharmaceutical and Healthcare Holdings
China Grand Pharmaceutical and Healthcare Holdings investment in Series A - Corisma
Adam Morley
Adam Morley investment in Seed Round - Corisma
Official Site Inspections
http://www.corismacv.com
- Host name: 104.21.15.216
- IP address: 104.21.15.216
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
